Is Abbott Laboratories (ABT) overvalued or fairly valued?

MarketChacha shows Abbott Laboratories's valuation in context — a forward P/E of about 16.8, a price-to-book of about 3.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Abbott Laboratories (ABT)?

Abbott Laboratories last traded at $101.66 (+1.0% on the day), as of 7/20/2026 — a delayed quote shown for education, not investment advice.

Abbott Laboratories

ABT · NYSE · Healthcare · United States

$101.66+1.0%

Delayed · as reported by Yahoo Finance · as of Jul 20, 2026, 8:03 PM

Snapshot

TickerABT

ExchangeNYSE

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees122,000

HeadquartersAbbott Park, United States

Market cap$177.4B

P/B3.4

Volume12.26M

Websitewww.abbott.com

Filings tracked0

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.5%
Institutions82.4%
Public & other17.1%

3,892 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.8.36%
Vanguard Capital Management LLC6.48%
State Street Corporation4.57%
Capital Research Global Investors2.86%
Vanguard Portfolio Management LLC2.75%
Charles Schwab Investment Management, Inc.2.61%
Geode Capital Management, LLC2.25%
Capital International Investors2.15%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $13.6B · EPS 1.63

Est. earnings growth +8.9%

Next fiscal year

Rev $54.6B · EPS 6.07

Est. earnings growth +10.2%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$81.9752-wk range$137.49

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about ABT

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.